Pelthos Therapeutics, Inc. (PTHS)
26.00
+3.26
(+14.34%)
USD |
NYAM |
Apr 08, 12:46
Pelthos Therapeutics Total Liabilities (Quarterly) : 91.52M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Lifecore Biomedical, Inc. | 198.12M |
| Ligand Pharmaceuticals, Inc. | 543.42M |
| InspireMD, Inc. | 14.20M |
| CytomX Therapeutics, Inc. | 53.49M |
| Cibus, Inc. | 283.22M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 130.40M |
| Shareholders Equity (Quarterly) | 38.88M |
| Debt to Equity Ratio | 0.8958 |
| Current Ratio | 2.027 |
| Net Debt Paydown Yield | -32.51% |